VERAXA Biotech Announces Regulatory Progress with its BiTACĀ®-TCE Development Plan

Go back to VERAXA Biotech Announces Regulatory Progress with its BiTACĀ®-TCE Development Plan
(NASDAQ: VRXA) Delayed: 1.80 -0.03 (1.64%)
Previous Close $1.83    52 Week High
Open $1.85    52 Week Low
Day High $1.86    P/E N/A 
Day Low $1.80    EPS
Volume 48,943